2022 October price disclosure cycle – confirmed prices and patient savings reports

1 October 2022 - Combination flow-on reduction outcomes reflect confirmed 1 October 2022 prices on the Current Price Disclosure cycle web ...

Read more →

2022 October price disclosure cycle – indicative prices

4 July 2022 - Indicative 1 October 2022 prices resulting from the 2022 October Cycle of Price Disclosure have now been ...

Read more →

Price disclosure 2022 October cycle outcomes summary

24 June 2022 - The summary of price disclosure price reductions for the 2022 October Cycle has now been published on ...

Read more →

Updated price disclosure guidelines, price disclosure webpages and price disclosure dispute resolution process

8 June 2022 - Amendments made to the National Health Act 1953 and National Health (Pharmaceutical Benefits) Regulations 2017 by the ...

Read more →

2022 April cycle - brand price reductions and savings to patients

31 March 2022 - Brand price reductions and savings to patients resulting from the 2022 April cycle of price disclosure have ...

Read more →

1 April 2022 price disclosure confirmed prices

15 March 2022 - Confirmed 1 April 2022 prices resulting from the 2022 April cycle of price disclosure have now been ...

Read more →

2022 April price disclosure cycle – indicative prices

27 January 2022 - Indicative 1 April 2022 prices resulting from the 2022 April Cycle of Price Disclosure have now been ...

Read more →

Price disclosure 2022 April cycle outcomes summary

10 December 2021 - The summary of price disclosure price reductions for the 2022 April Cycle has now been published ...

Read more →

1 October 2021 price disclosure confirmed prices

13 September 2021 - Confirmed 1 October 2021 prices resulting from the 2021 October cycle of price disclosure have now been ...

Read more →

2021 October price disclosure cycle – indicative prices

30 August 2021 - Indicative 1 October 2021 prices resulting from the 2021 October Cycle of Price Disclosure have now ...

Read more →

Price disclosure 2021 October cycle outcomes summary

23 June 2021 - The summary of price disclosure price reductions for the 2021 October cycle has now been published. ...

Read more →

Department of Health publishes Public Summary Document for medicine without a published outcome

8 March 2021 - The Department of Health has published a Public Summary Document for mometasone furoate with indacaterol maleate ...

Read more →

More startling revelations from the Public Summary Document for upadacitinib monohydrate (Rinvoq)

8 March 2021 - Take a seat before reading any further. ...

Read more →

2021 April price disclosure cycle – indicative prices

20 January 2021 - Indicative 1 April 2021 prices resulting from the 2021 April Cycle of Price Disclosure have now been ...

Read more →

1 October 2020 price disclosure - confirmed prices

6 October 2020 - Confirmed 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure has now been ...

Read more →